Statistics show that since October 18, the People's Bank of China, together with the China Banking and Insurance Regulatory Commission and the China Securities Regulatory Commission, officially established share buyback and shareholding rediscount loans, as of November 29, 21 STAR Market listed companies have disclosed plans related to share buyback and shareholding special loans, accounting for approximately 11% of the total number of related companies in the A-share market. Among them, 9 companies have basically implemented the related plans: ArtSign intends to sign a loan contract; Orinko Advanced Plastics has signed a loan contract; PharmaKang Biological, Ler Technology, Suzhou Jinhong Gas Co., Ltd. have signed borrowing contracts; Shanghai MicroPort Endovascular Medtech(Group)Co., Ltd., Weider Information, Eisen Stock, and Asia Vets have received loan commitment letters/documents from relevant banks. In terms of the planned amount of special loans to be used, ArtSign is currently the company with the highest planned loan amount in the STAR Market, with a planned loan amount not exceeding 0.4 billion yuan; STAR Market listed companies with planned loan amounts exceeding 0.1 billion yuan also include Shanghai MicroPort Endovascular Medtech(Group)Co.,Ltd., and Asia Vets, with planned loans of 0.14 billion yuan and 0.2 billion yuan respectively.